5Yi Y,Zhang GS, Xu M, et al. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families. Clinica Chimica Acta, 2006,373:49-54.
6Arrondel C,Vodovar N, Knebehnann B, et al. Expression of the nonmuscle myosin heavy chain ⅡA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol, 2002, 13:65-74.
7Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain Ⅱ A mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet, 2001, 69: 1033-1045.
8Seri M, Pecci A, Di Bari F,et al. MYH9- related disease May- Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distincl entities but represent a variable expression of a single illness. Medicine( Baltimore), 2003, 82 : 203 -215.
9Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet,2000, 26 : 103-105.
